New ADRENALIN® IV Bag Line To Make Emergency Care Efficient

ADRENALIN® IV Bag

Follow Us:

September 24, 2025

Overview :

Endo Pharmaceuticals has expanded its ADRENALIN® (IV) bag product line by adding three new concentrations. The 2 mg, 5 mg, and 10 mg per 250 mL range has been added to these ready-to-use bags. This move aims to make emergency care faster and safer by reducing preparation steps and medication errors in hospitals.

With the addition of these new formulations, Endo Pharmaceuticals now offers a total of five premixed concentrations. The 5 mg and 10 mg doses match the American Society of Health-System Pharmacists’ (ASHP) Standardize 4 Safety Initiative, which promotes consistent medication practices across hospitals nationwide.

Faster Response in Emergency Care

Emergencies often require quick, precise medication delivery. Traditionally, healthcare teams mix epinephrine solutions manually. It is a process that can be time-consuming and prone to human error.

According to Endo Pharmaceuticals, the new ready-to-use ADRENALIN® IV bags will save valuable time by eliminating the need for manual preparation. This improvement can be critical during life-threatening emergencies such as cardiac arrest, severe allergic reactions, or shock.

Standardised Dosing To Reduce Errors

Medication errors remain a major challenge in hospitals. A report from the Institute of Medicine estimates that medication errors harm at least 1.5 million people annually in the United States.

This move of Endo Pharmaceuticals will standardise concentrations, aiming to address this issue by:

  • Simplifying workflows for pharmacists and nurses.
  • Reducing calculation mistakes when preparing doses.
  • Improving consistency across different hospital settings.

The ASHP Standardize 4 Safety Initiative, launched in 2018, sets national guidelines for drug concentrations in ready-to-use formats. Endo Pharmaceuticals’ new 5 mg and 10 mg IV bags align directly with these standards, supporting safer practices in hospitals.

Benefits for Hospital Pharmacies

Hospital pharmacies often struggle with medication shortages and preparation challenges. By introducing premixed ADRENALIN® IV bags, Endo Pharmaceuticals is helping:

  • Lower staff workload by cutting down on manual mixing tasks.
  • Reduce waste, since premixed solutions have longer shelf lives than compounded products.
  • Enhance safety compliance, as standardised doses meet regulatory guidelines.

Impact on Emergency Departments

Emergency departments (EDs) are high-pressure environments where medication must be ready at a moment’s notice. Manual compounding during emergencies can delay treatment.

With these new ready-to-use ADRENALIN® IV bags, ED teams can:

  • Administer medication quickly, especially during cardiac arrest or anaphylaxis.
  • Ensure accurate dosing, even when multiple patients require care at the same time.
  • Focus on patient stabilisation, instead of time-consuming preparation processes.

This improvement is especially important in rural hospitals or facilities with limited staff, where every resource counts.

About ADRENALIN® (Epinephrine Injection, USP)

ADRENALIN® is a widely used medication for treating:

  • Severe allergic reactions (anaphylaxis)
  • Cardiac arrest
  • Severe asthma attacks
  • Shock from severe infections or trauma

Epinephrine works by increasing blood pressure, improving heart function, and relaxing airway muscles, making it a cornerstone drug in emergency medicine.

Commitment to Safety and Innovation

Endo Pharmaceuticals has stated that this expansion reflects its ongoing commitment to patient safety and healthcare innovation. While the company has not shared details about product availability, it emphasised its goal of supporting hospitals and clinicians with reliable, standardised solutions.

Conclusion

As hospitals continue to face challenges like staffing shortages and increased patient loads, demand for ready-to-use medications is expected to grow. This expansion of the ADRENALIN® IV bag line positions the company as a key player in this shift toward simpler, safer drug administration practices.

By offering a wider range of standardised concentrations, the company helps healthcare providers deliver faster, safer, and more reliable care during emergencies. It ensures that lifesaving medications are ready the moment they’re needed when every second truly counts.

Scroll to Top